CINTICHEM TECHNETIUM 99M HEDSPA
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Nov 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CINTICHEM TECHNETIUM 99M HEDSPA is a diagnostic radiopharmaceutical administered by injection for nuclear medicine imaging. The specific mechanism of action and therapeutic indications are not publicly documented in available data. This product represents a legacy diagnostic imaging agent from the GE HealthCare portfolio.
LOE Approaching
As a legacy diagnostic agent approaching loss of exclusivity with minimal linked job activity, the brand team is likely small and focused on managed decline rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CINTICHEM TECHNETIUM 99M HEDSPA offers minimal career growth potential given zero linked job openings and impending loss of exclusivity. This role is best suited for professionals seeking stable maintenance responsibility or preparing for portfolio transitions rather than career advancement.
Product ManagerMarket Access Specialist
Worked on CINTICHEM TECHNETIUM 99M HEDSPA at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.